FDA warned a Hims & Hers compounder after finding bugs and failing to report a serious side effect The FDA inspected MedisourceRx months after Hims & Hers acquired the compounder

https://www.statnews.com/pharmalot/2026/02/09/fda-inspection-warns-hims-compounder-bugs-wegovy/ By Ed SilvermanFeb. 9, 2026 Pharmalot Columnist, Senior Writer Lawsuit against Hims & Hers should be ‘wake-up call’ for compounders, Novo chief counsel says In interview, attorney for Danish drugmaker says compounding of Wegovy pill is a ‘tipping point’ https://www.statnews.com/pharmalot/2026/02/09/hims-novo-lawsuit-chief-counsel-interview/ By Elaine Chen and Ed SilvermanFeb. 9, 2026